Table 6 Characteristics of all obese participants separated based on VO2 max responders after exercise.

From: Spexin as an indicator of beneficial effects of exercise in human obesity and diabetes

 

Non-responders (N = 14)

Responders (N = 33)

Markers

Pre

Post

Variation

P values

Pre

Post

Variation

P values

BMI (kg/m2)

33.18 ± 2.17

32.36 ± 4.53

− 0.82 ± 1.13

0.189

33.27 ± 2.76

32.80 ± 3.17

− 0.47 ± 0.84

0.373

Waist (cm)

107.57 ± 6.88

103.14 ± 9.63

− 4.43 ± 6.58

0.186

104.73 ± 10.95

102.80 ± 8.46

− 1.93 ± 2.49

0.259

Hip (cm)

111.21 ± 5.79

108.61 ± 6.99

− 2.60 ± 1.94

0.304

116.00 ± 7.64

113.25 ± 7.36

− 2.75 ± 4.14

0.239

PBF (%)

36.02 ± 3.52

34.48 ± 4.37

− 1.54 ± 1.32

0.160

37.15 ± 5.84

36.58 ± 5.75

− 0.57 ± 0.73

0.168

WBC10

6.44 ± 1.32

5.68 ± 1.17

− 0.76 ± 0.58

0.139

6.51 ± 1.94

6.68 ± 1.67

0.17 ± 0.22

0.679

SBP (mmHg)

115.71 ± 7.87

116.43 ± 4.76

0.72 ± 1.65

0.805

115.45 ± 9.34

114.73 ± 8.76

− 0.72 ± 1.92

0.437

DBP (mmHg)

77.14 ± 4.88

77.86 ± 2.67

0.71 ± 1.21

0.788

76.55 ± 5.22

75.00 ± 5.48

− 1.55 ± 2.13

0.846

Resting HR (beats/min)

83.86 ± 11.02

81.43 ± 14.11

− 2.43 ± 4.67

0.608

82.00 ± 6.71

75.55 ± 8.56

− 6.45 ± 4.39

0.042

VO2, max (ml/kg/min)

17.68 ± 2.97

17.18 ± 3.55

− 0.50 ± 0.28

0.462

17.89 ± 3.40

21.66 ± 4.70

3.77 ± 2.85

0.001

TC (mmol/l)

5.23 ± 1.14

5.34 ± 1.37

0.11 ± 0.29

0.767

4.79 ± 1.04

4.30 ± 0.93

− 0.49 ± 0.96

0.142

HDL (mmol/l)

1.24 ± 0.34

1.27 ± 0.40

0.03 ± 0.38

0.649

1.20 ± 0.37

1.21 ± 0.61

0.01 ± 0.32

0.906

LDL (mmol/l)

3.15 ± 1.30

3.62 ± 1.17

0.47 ± 0.42

0.384

2.96 ± 1.12

2.57 ± 0.66

− 0.39 ± 0.72

0.263

TG (mmol/l)

1.35 ± 0.89

1.37 ± 0.77

0.02 ± 0.19

0.963

1.16 ± 0.40

1.44 ± 0.90

0.28 ± 0.62

0.400

FBG (mmol/l)

6.37 ± 2.07

6.11 ± 2.13

− 0.26 ± 0.39

0.532

6.07 ± 1.07

5.85 ± 1.02

− 0.22 ± 0.46

0.158

HbA1c (%)

6.59 ± 1.49

6.34 ± 1.55

− 0.25 ± 0.27

0.134

6.34 ± 0.92

6.00 ± 0.71

− 0.34 ± 0.59

0.066

Insulin (ng/ml)

4.81 ± 2.12

3.61 ± 1.21

− 1.20 ± 1.09

0.156

5.40 ± 2.70

4.52 ± 2.11

− 0.88 ± 1.52

0.476

C-peptide (ng/ml)

11.32 ± 13.34

6.23 ± 7.31

− 5.09 ± 3.17

0.154

2.36 ± 1.15

2.98 ± 1.65

0.62 ± 0.42

0.290

HOMA-IR

1.72 ± 1.46

1.33 ± 1.15

− 0.39 ± 0.69

0.323

1.61 ± 0.80

1.14 ± 0.51

− 0.47 ± 0.94

0.205

hsCRP (μg/ml)

2.12 ± 1.67

1.62 ± 1.46

− 0.50 ± 0.21

0.178

3.85 ± 1.19

1.22 ± 0.59

− 2.63 ± 1.68

0.025

  1. Data are presented as the mean ± SD.
  2. BMI body mass index, PBF percent body fat, SBP systolic blood pressure, DBP diastolic blood pressure, HR heart rate, VO2, max maximum oxygen consumption, TC total cholesterol, HDL high-density lipoprotein, LDL low-density lipoprotein, TG triglyceride, FBG fasting blood glucose, HbA1c hemoglobin A1c, HOMA-IR Homeostatic Model Assessment for Insulin Resistance, hsCRP high-sensitivity C-reactive protein.
Back to article page